New York State Teachers Retirement System Has $7.39 Million Stock Position in DaVita Inc. (NYSE:DVA)

New York State Teachers Retirement System trimmed its position in shares of DaVita Inc. (NYSE:DVA - Free Report) by 10.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 49,438 shares of the company's stock after selling 5,594 shares during the quarter. New York State Teachers Retirement System owned 0.06% of DaVita worth $7,393,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in DVA. FMR LLC boosted its position in shares of DaVita by 659.9% during the third quarter. FMR LLC now owns 177,406 shares of the company's stock worth $29,082,000 after purchasing an additional 154,061 shares in the last quarter. Glenmede Trust Co. NA boosted its position in shares of DaVita by 731.6% during the third quarter. Glenmede Trust Co. NA now owns 123,269 shares of the company's stock worth $20,207,000 after purchasing an additional 108,446 shares in the last quarter. JPMorgan Chase & Co. boosted its position in shares of DaVita by 17.8% during the third quarter. JPMorgan Chase & Co. now owns 609,076 shares of the company's stock worth $99,846,000 after purchasing an additional 92,014 shares in the last quarter. KBC Group NV lifted its position in DaVita by 27.3% in the 3rd quarter. KBC Group NV now owns 313,519 shares of the company's stock valued at $51,395,000 after acquiring an additional 67,250 shares in the last quarter. Finally, International Assets Investment Management LLC bought a new stake in DaVita in the 3rd quarter valued at $10,346,000. 90.12% of the stock is owned by institutional investors.

Analyst Ratings Changes

Separately, Barclays boosted their price objective on shares of DaVita from $164.00 to $169.00 and gave the company an "equal weight" rating in a research report on Tuesday. One analyst has rated the stock with a sell rating, three have given a hold rating and two have given a buy rating to the company. According to MarketBeat.com, DaVita currently has an average rating of "Hold" and an average target price of $162.80.

DaVita Stock Performance

Shares of DaVita stock traded down $3.59 during trading on Friday, hitting $142.33. 1,605,084 shares of the stock were exchanged, compared to its average volume of 983,216. The stock has a market capitalization of $11.39 billion, a price-to-earnings ratio of 13.25, a price-to-earnings-growth ratio of 1.07 and a beta of 0.94. The company has a fifty day moving average price of $161.03 and a 200-day moving average price of $157.86. DaVita Inc. has a 1-year low of $120.78 and a 1-year high of $179.60. The company has a current ratio of 1.26, a quick ratio of 1.21 and a debt-to-equity ratio of 23.18.

DaVita (NYSE:DVA - Get Free Report) last released its quarterly earnings data on Thursday, February 13th. The company reported $2.24 earnings per share for the quarter, topping the consensus estimate of $2.14 by $0.10. DaVita had a net margin of 7.31% and a return on equity of 115.48%. As a group, equities analysts predict that DaVita Inc. will post 10.76 EPS for the current fiscal year.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.